XTX Topco’s Kazia Therapeutics KZIA Stock Holding History

XTX Topco’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-468	Closed	-$10.1K	–	2632
2024 Q3	$10.1K	Buy	+468	New	+$9.34K	﹤0.01%	1919
2024 Q2	–	Sell	-370	Closed	-$5.81K	–	2183
2024 Q1	$5.81K	Sell	370 -19	-5%	-$285	﹤0.01%	1709
2023 Q4	$8.73K	Buy	+389	New	+$11.4K	﹤0.01%	1437

Other funds holding KZIA

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

XTX Topco's KZIA Position: Q4 2024 in Review

XTX Topco sold out of Kazia Therapeutics (KZIA) in Q4 2024, closing a stake of 468 shares — an estimated $10.1K sold.

XTX Topco first reported a position in KZIA in Q4 2023 and held it in 3 quarters. The position peaked at $10.1K in Q3 2024. 10 funds tracked by Wall St. Rank hold KZIA as of Q4 2024.

XTX Topco reported no remaining Kazia Therapeutics position as of Q4 2024 after selling out during the quarter.
XTX Topco sold 468 Kazia Therapeutics shares in Q4 2024, an estimated $10.1K.
XTX Topco first reported a position in Kazia Therapeutics in Q4 2023 and held it in 3 quarters.
XTX Topco's Kazia Therapeutics position peaked at $10.1K in Q3 2024.
10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.